NF-κB Is Activated in CD4+ iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A2A Receptors

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Lin, Gene ^a   Field, Joshua J ^b   Yu, Jennifer C ^a   Ken, Ruey ^a   Neuberg, Donna ^c   Nathan, David G ^c   Linden, Joel ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ADENOSINE A2A RECEPTOR; I KAPPA B KINASE INHIBITOR; I KAPPA B KINASE INHIBITOR VII; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7F6 G5 A2; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CD4+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INVARIANT NATURAL KILLER T LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SICKLE CELL ANEMIA; VASO OCCLUSIVE CRISIS;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; RECEPTOR, ADENOSINE A2A; YOUNG ADULT;

EID: 84885079141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074664     Document Type: Article

References (45)

1. Cao Z, Yuan Y, Jeyabalan G, Du Q, Tsung A, et al. (2009) Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor. Am J Physiol Gastrointest Liver Physiol 297: G249-258.
2. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J, (2006) Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203: 2639-2648.
3. Li L, Huang L, Sung SS, Lobo PI, Brown MG, et al. (2007) NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. Journal of immunology 178: 5899-5911.
4. Brittain JE, Han J, Ataga KI, Orringer EP, Parise LV, (2004) Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes. The Journal of biological chemistry 279: 42393-42402.
5. Hebbel RP, Moldow CF, Steinberg MH, (1981) Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood 58: 947-952.
6. Platt OS, (2000) Sickle cell anemia as an inflammatory disease. The Journal of clinical investigation 106: 337-338.
7. Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, et al. (2009) NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood 114: 667-676.
8. Wallace KL, Linden J (2010) Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood.
9. Linden J, (2012) Role of adenosine in response to vascular inflammation. Arterioscler Thromb Vasc Biol 32: 843-844.
10. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J, (2006) Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. The Journal of experimental medicine 203: 2639-2648.
11. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, et al. (1991) Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325: 11-16.
12. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV, (1999) Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol 55: 614-624.
13. Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J, (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. The Journal of comparative neurology 401: 163-186.
14. Bessoles S, Fouret F, Dudal S, Besra GS, Sanchez F, et al. (2008) IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines. J Leukoc Biol 84: 224-233.
15. Kronenberg M, Engel I, (2007) On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Current opinion in immunology 19: 186-193.
16. Exley MA, Hou R, Shaulov A, Tonti E, Dellabona P, et al. (2008) Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. European journal of immunology 38: 1756-1766.
17. O'Reilly V, Zeng SG, Bricard G, Atzberger A, Hogan AE, et al. (2011) Distinct and overlapping effector functions of expanded human CD4+, CD8alpha + and CD4-CD8alpha- invariant natural killer T cells. PloS one 6: e28648.
18. Stanic AK, Bezbradica JS, Park JJ, Van Kaer L, Boothby MR, et al. (2004) Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-κ B. Journal of immunology. 172: 4667-4671.
19. Field JJ, Lin G, Okam MM, Majerus E, Keefer J, et al. (2013) Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood.
20. Hayden MS, Ghosh S, (2008) Shared principles in NF-κB signaling. Cell 132: 344-362.
21. Hettinger BD, Lee A, Linden J, Rosin DL, (2001) Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. The Journal of comparative neurology 431: 331-346.
22. Glover DK, Ruiz M, Takehana K, Petruzella FD, Rieger JM, et al. (2007) Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. American journal of physiology Heart and circulatory physiology 292: H3164-3171.
23. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, et al. (2006) Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114: 2056-2064.
24. Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, et al. (2003) Transgenic sickle mice have vascular inflammation. Blood 101: 3953-3959.
25. Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, et al. (2005) Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. American journal of physiology Heart and circulatory physiology 288: H2715-2725.
26. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM, (2000) Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96: 2451-2459.
27. Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, et al. (2010) P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arteriosclerosis, thrombosis, and vascular biology 30: 2392-2399.
28. Gumperz JE, Miyake S, Yamamura T, Brenner MB, (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. The Journal of experimental medicine 195: 625-636.
29. Lee PT, Benlagha K, Teyton L, Bendelac A, (2002) Distinct functional lineages of human V(alpha)24 natural killer T cells. The Journal of experimental medicine 195: 637-641.
30. Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, et al. (2007) CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood 110: 251-258.
31. Kollander R, Solovey A, Milbauer LC, Abdulla F, Kelm RJ Jr, et al. (2010) Nuclear factor-κ B (NFκB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease. Translational research: the journal of laboratory and clinical medicine 155: 170-177.
32. Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, et al. (2011) Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nature immunology 12: 1202-1211.
33. Bourgeois E, Van LP, Samson M, Diem S, Barra A, et al. (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. European journal of immunology 39: 1046-1055.
34. Wang X, Bishop KA, Hegde S, Rodenkirch LA, Pike JW, et al. (2012) Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. The Journal of experimental medicine 209: 987-1000.
35. Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J, (2001) Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. British journal of pharmacology 132: 1017-1026.
36. Murphree LJ, Sullivan GW, Marshall MA, Linden J, (2005) Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-κB in A(2A) adenosine receptor induction. The Biochemical journal 391: 575-580.
37. Lappas CM, Rieger JM, Linden J, (2005) A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. Journal of immunology 174: 1073-1080.
38. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. The Journal of experimental medicine 204: 1257-1265.
39. Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, et al. (2008) A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
40. Linden J, Cekic C, (2012) Regulation of lymphocyte function by adenosine. Arteriosclerosis, thrombosis, and vascular biology 32: 2097-2103.
41. Pritchard KA Jr, Feroah TR, Nandedkar SD, Holzhauer SL, Hutchins W, et al. (2012) Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice. American journal of respiratory cell and molecular biology 46: 389-396.
42. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A, (2005) Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 60: 206-210.
43. Field JJ, Stocks J, Kirkham FJ, Rosen CL, Dietzen DJ, et al. (2011) Airway hyperresponsiveness in children with sickle cell anemia. Chest 139: 563-568.
44. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
45. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, et al. (1998) A2A-adenosine receptor reserve for coronary vasodilation. Circulation 98: 711-718.